Basic Information
ID: ALA646073
Type: Functional
Description: In vitro presynaptic antagonist potency at alpha-2 adrenergic receptor in rat or mouse vas deferens relative to compound 5 (RX781094)
Format: BAO_0000221
Tissue: Vas deferens
Target: Adrenergic receptor alpha-2(ALA2093864)
Document: ALA1122229
In vitro presynaptic antagonist potency at alpha-2 adrenergic receptor in rat or mouse vas deferens relative to compound 5 (RX781094): 1
Activity Charts
Bioactivity
Activity Types for Assay ALA646073
Antagonist potency
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 178.19 | 0.76 | 0.76 |
| 202.21 | 1.92 | 1.92 |
| 218.26 | 1.22 | 1.22 |
| 244.29 | 2.29 | 2.29 |
| 216.24 | 1.79 | 1.79 |
| 358.39 | 2.28 | 2.28 |
| 236.27 | 0.57 | 0.57 |
| 282.34 | 2.64 | 2.64 |
| 233.23 | 1.03 | 1.03 |
| 273.12 | 2.13 | 2.13 |
| 273.12 | 2.13 | 2.13 |
| 216.24 | 1.72 | 1.72 |
| 232.28 | 1.61 | 1.61 |
| 218.26 | 1.17 | 1.17 |
| 254.29 | 1.98 | 1.98 |
| 218.26 | 1.22 | 1.22 |
| 252.27 | 3.08 | 3.08 |
| 218.26 | 1.14 | 1.14 |
| 260.34 | 2.13 | 2.13 |
| 290.41 | 3.41 | 3.41 |
| 246.31 | 2.29 | 2.29 |
| 218.26 | 1.14 | 1.14 |
| 218.26 | 1.22 | 1.22 |
| 218.26 | 1.14 | 1.14 |